Renal fibrosis is the final common pathway of a wide variety of chronic kidney diseases. Myofibroblast formation via the differentiation of from tissue-resident fibroblasts and bone marrow-derived mesenchymal stem cells (MSCs), and epithelial-to-mesenchymal transition (EMT) is known to play a pivotal role in the development of renal fibrosis. However, the detailed mechanisms underlying this disorder remain unclear. We herein investigated the role of alpha 2-antiplasmin (a2AP) in myofibroblast formation and the development of renal fibrosis. We observed the development of renal fibrosis using unilateral ureteral obstruction (UUO). a2AP had accumulated in the UUO-induced obstructed kidneys and a2AP deficiency attenuated UUO-induced renal fibrosis in mice. The degree of myofibroblast formation in the obstructed kidneys of a2AP 2/2 mice was less than that in a2AP 1/1 mice. In vitro, a2AP induced myofibroblast formation in renal tubular epithelial cells (RTECs), renal fibrosblasts, and bone marrow-derived mesenchymal stem cells (MSCs). a2AP also induced the production of TGF-b, which is known to be a key regulator of myofibroblast formation and fibrosis. a2AP-induced the TGF-b production was significantly reduced by SP600125, c-Jun N-terminal kinase (JNK) specific inhibitor. Our findings suggest that a2AP induces myofibroblast formation in the obstructed kidneys, and mediates the development of renal fibrosis. R enal fibrosis is the final common pathway of chronic kidney diseases including diabetic nephropathy and glomerulonephritis, and is characterized by the excessive production, deposition, and contraction of the extracellular matrix (ECM). Renal fibrosis represents one of the largest groups of disorders for which there is no effective therapy. The lack of appropriate antifibrotic therapy arises primarily from the fact that the etiology of renal fibrosis is unknown. The development of renal fibrosis is generally considered to result from maladaptive repair processes induced by the release of a variety of profibrotic factors such as transforming growth factor-beta (TGF-b), in which infiltrating inflammatory cells including macrophages, stimulate the formation of myofibroblasts via the differentiation from tissue-resident fibroblasts and bone marrow-derived mesenchymal stem cells (MSCs), and epithelial-to-mesenchymal transition (EMT). The accumulated myofibroblasts subsequently synthesize and deposit components of the extracellular matrix (ECM) [1] [2] [3] [4] . Alpha2-antiplasmin (a2AP) is a serine protease inhibitor (serpin) with a molecular weight of 65 to 70 kDa 5 that rapidly inactivates plasmin, thus resulting in the formation of a stable inactive complex, plasmin-a2AP 6 . Many studies have reported that the levels of the plasmin-a2AP complex in the plasma are elevated in patients with fibrotic diseases, including diabetic nephropathy, systemic sclerosis, liver cirrhosis and rheumatoid arthritis [7] [8] [9] [10] . Recently, we found that a2AP is associated with wound healing 11 and the development of dermal fibrosis [12] [13] [14] . We also demonstrated that a2AP induces the production of TGF-b, which is known to be a key regulator of the formation of myofibroblasts and the development of fibrosis. We herein report the role of a2AP in the formation of myofibroblasts and the development of renal fibrosis.
Methods
The animal experiments in this study were approved by the Animal Research Committee of Doshisha Women's Collage of Liberal Arts (Approval ID: Y13-017).
Animals. Deficient mice were generated by homologous recombination using embryonic stem cells, as described previously 15, 16 . All experiments were performed in accordance with institutional guidelines.
Reagents. a2AP was purchased from Calbiochem (CA, USA). Other chemical substances were obtained from Sigma (MO, USA).
Unilateral ureteral obstruction (UUO). UUO was performed as described by Miyajima et al 17 . Male mice 8 to 12 weeks of ages were used for the experiments. The left ureter of each mouse was ligated under general anesthesia. The degree of renal injury was studied at 2 or 7 days after UUO (n 5 4 mice per group).
Collagen content in kidney (The sircol biochemical assay). The collagen content was measured as previously described 18 . The collagen content was assessed using Sirius red staining. In these assays, sections are stained with Sirius red as described by Junqueira et al 19 . After deparaffinization, the sections are treated in 0.2% phosphomolybdic acid for 5 minutes. Next, the section stained in 0.1% Sirius red for 90 minutes and 0.01 N HCl for 2 minutes. The stained images obtained from separate fields on the specimens (n 5 4) were analyzed by using ImageJ. Sirius red positive area was expressed as a percent of the observed with sham mice.
Primary murine renal tubular epithelial cells. Primary murine renal tubular epithelial cells were obtained as described by Sato et al 20 . The minced kidneys were washed with three changes of cold PBS containing 1 mM EDTA and digested in 0.25% trypsin solution in a shaking incubator at 37uC for 2 hours. Trypsin was neutralized with Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum (FCS). The suspension was triturated using pipetting and passed through a 70 mm cell strainer. The cells were seeded onto 60-mm diameter dishes and maintained in DMEM containing 10% FCS at 37uC in a humidified atmosphere of 5% CO 2 /95% air. The experiments were carried out in serum-free DMEM.
Primary murine renal fibroblasts. Primary murine renal fibroblasts were obtained as described by Muller et al 21 . The renal cortex was dissected from the kidney, minced and suspended in DMEM containing 10% FCS. The cells were cultured in DMEM containing 10% fetal calf serum (FCS) at 37uC in a humidified atmosphere of 5% CO 2 / 95% air, and after two to three passages, only fibroblasts survived under the culture conditions. The cells were seeded onto 60-mm diameter dishes, and maintained in DMEM containing 10% FCS at 37uC in a humidified atmosphere of 5% CO 2 /95% air. The experiments were carried out in serum-free DMEM.
Mesenchymal stem cell isolation, cells culture. Bone marrow cells were obtained as described by Kanno et al 22 . The cells were seeded, and then were maintained in DMEM containing 10% fetal calf serum (FCS) at 37uC in a humidified atmosphere of 5% CO 2 /95% air. Nonadherent cells were removed by 2-3 washes with PBS and adherent cells further cultured in DMEM containing 10% fetal calf serum (FCS).
Western blot analysis. We studied a Western blot analysis as previously described 23 .
We detected a2AP, a-SMA, E-cadherin and vimentin, TGF-b by incubation with anti-a2AP antibody, anti-a-SMA antibody, anti-E-cadherin antibody, anti-vimentin antibody and anti-TGF-b antibody followed incubation with horseradish peroxidaseconjugated antibody to rabbit IgG.
Statistical analysis. All data are expressed as mean 6 SEM. The significance of the effect of each treatment (P , 0.05) was determined by analysis of variance (ANOVA) followed by the Least significant difference test.
Results
The accumulation of a2AP was induced in the obstructed kidney.
We assessed the levels of UUO-induced renal fibrosis using Sirius red staining. The degree of Sirius red-positive areas in the obstructed kidneys at 7 days was significantly increased in comparison to that observed in the controls (Fig. 1A, B) . To clarify the role of a2AP in renal fibrosis, we examined the expression of a2AP in the kidneys following UUO surgery by a Western blot analysis. We found that a2AP had accumulated in the obstructed kidneys (Fig. 1C) .
a2AP deficiency attenuated UUO-induced renal fibrosis. We assessed the levels of UUO-induced renal fibrosis in the a2AP 1/1 and a2AP 2/2 mice using Masson trichrome and Sirius red staining. The degree of Sirius red-positive areas in the obstructed kidneys in the a2AP 2/2 mice was significantly reduced in comparison to that observed in the a2AP 1/1 mice ( Fig. 2A, B) .
The effect of a2AP deficiency on myofibroblast formation and EMT in the obstructed kidneys. To clarify the effects of a2AP deficiency on myofibroblast formation and EMT in obstructed kidneys, we examined the expression of alpha-smooth muscle actin (a-SMA) (a hallmark of the myofibroblast phenotype), two EMT biomarkers (upregulation of vimentin and downregulation of Ecadherin) in the obstructed kidney of the a2AP 1/1 and a2AP 2/2 mice (Fig. 3) . The degree of a-SMA-positive areas in the obstructed kidneys of the a2AP 2/2 mice was significantly lower than that observed in the a2AP 1/1 mice. In addition, the degree of upregulation of vimentin and downregulation of E-cadherin in the obstructed kidneys of the a2AP 2/2 mice was lower than that observed in the a2AP 1/1 mice.
a2AP was associated with myofibroblast formation. To clarify the role of a2AP on myofibroblast formation, the renal tubular epithelial cells (RTECs), renal fibroblasts and bone marrow-derived mesenchymal stem cells (MSCs) were stimulated by a2AP. a2AP induced the expression of a-SMA, the upregulation of vimentin and the downregulation of E-cadherin in RTECs (Fig. 4A) . a2AP also induced the expression of a-SMA in renal fibroblasts (Fig. 4B) . Moreover, a2AP induced the expression of a-SMA in bone marrow-derived MSCs (Fig. 4C) .
a2AP induced the production of TGF-b. It has known that TGF-b stimulates the formation of myofibroblasts. Therefore, we examined whether a2AP is associated with the production of TGF-b in renal fibroblasts. a2AP induced the production of TGF-b in renal fibroblasts (Fig. 5A ). The stimulation of a2AP also induced the production of type I collagen and fibronectin (FN) (Fig. 5A ). In addition, the phosphorylation of smad2/3 in a2AP-stimulated cells was increased in a dose-dependent manner (Fig. 5B) . The effect of a2AP in the production of TGF-b was seen up to 24 hours after stimulation, after which it decreased (Fig. 5C ). Previously, we demonstrated that a2AP induces the production of TGF-b through JNK pathway 13 . Therefore, we examined whether the JNK pathway is associated with the a2AP-induced TGF-b production by using JNK specific inhibitors (SP600125). SP600125 attenuated the a2AP-induced TGF-b production in renal fibroblasts (Fig. 5D ).
Discussion
The development of renal fibrosis is induced by various factors that stimulate the formation of myofibroblasts, which then synthesize and deposit components of the ECM. However, the mechanisms underlying the formation of myofibroblasts and the development of renal fibrosis are not precisely understood. In this study, we demonstrated the role of a2AP in the formation of myofibroblasts and the development of renal fibrosis.
a2AP has accumulated in the UUO-induced obstructed kidney (Fig. 1) . In addition, a2AP deficiency attenuated UUO-induced renal fibrosis (Fig. 2) . Plasmin can directly degrade some matrix proteins (fibronectin, laminin, entactin, tenascin, thrombospondin and perlecan), indirectly degrade several other matrix proteins by activating latent metalloproteinases (MMPs) and degrade fibrin, which can serve as a provisional matrix scaffold for the initiation of a fibrotic response 24 . Our previous study demonstrated that a2AP inhibits the plasmin activity 25 , and the inhibition of plasmin may slow ECM degradation and attenuate renal fibrosis. However, it has also been reported that plasmin does not attenuate renal fibrosis 26 . The activation of plasmin is mediated by urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA). The inhibition of the system may occur through the neutralization of the plasminogen activators or plasmin, and this neutralization is achieved mainly by the plasminogen activator inhibitor-1 (PAI-1) or a2AP, respectively. uPA also has no antifibrotic activity in renal injury 27 . On the other hand, although PAI-1 or tPA deficiency attenuated the UUOinduced renal fibrosis, both PAI-1 and tPA deficiency had no effect on plasmin activity 28, 29 . These studies suggest that a2AP deficiencyattenuated renal fibrosis does not result from the enhancement of the plasmin activity due to a deficiency of a2AP and that a2AP itself is associated with the development of renal fibrosis and may function as a local regulator of fibrotic changes.
To clarify the role of a2AP itself in the development of renal fibrosis, we focused the formation of myofibroblasts in obstruct kidney. Myofibroblasts are known to be key effector cells in the development of fibrosis, and myofibroblast formation is promoted by EMT, the differentiation from tissue-resident fibroblasts and bone marrow-derived MSCs 4, 30 . a2AP deficiency attenuated UUO-induced myofibroblast formation (Fig. 3) , and a2AP induced myofibroblast formation in RTECs, renal fibroblasts and bone marrow-derived MSCs (Fig. 4) . In addition, a2AP deficiency attenuated UUOinduced the upregulation of vimentin and the downregulation of E-cadherin (Fig. 3) , and a2AP induced the upregulation of vimentin and the downregulation of E-cadherin in RTECs (Fig. 4) . These data suggest that the myofibroblast formation induced by a2AP is associated with EMT, the differentiation from tissue-resident fibroblatsts and bone marrow-derived MSCs.
It has reported that TGF-b plays a pivotal role in myofibroblast formation, including EMT and the differentiation of fibroblasts. Preiviously, we demonstrated that a2AP induces the production of TGF-b [12] [13] [14] . We showed that a2AP induced the production of TGF-b in renal fibroblasts (Fig. 5A) . We also showed that a2AP induced ECM protein such as type I collagen and FN. It has known that TGFb induces myofibroblast formation and the synthesis of ECM protein. TGF-b production induced by a2AP may be associated with myofibroblast formation and ECM deposition. A variety of molecules including plasmin, thrombospondin-1, integrins have been reported as TGF-b activator 31 . Therefore, we examined that the relationship of a2AP and TGF-b activity. The stimulation of a2AP did not interfere with TGF-b signalling (Fig. 5B) . Moreover, we showed that the a2AP-induced TGF-b production was associated with JNK pathway (Fig. 5D) . JNK pathway is involved in the fibrotic changes such as collagen synthesis and the induction of TGF-b expression [32] [33] [34] [35] , a2AP may mediate the development of renal fibrosis through JNK pathway. In conclusion, a2AP induces the formation of myofibroblasts via EMT and the differentiation of tissue-resident fibroblasts and bone marrow-MSCs, and mediates the development of renal fibrosis. Our findings may provide new insight into this process, which could eventually lead to the development of new clinical therapies for the prevention of fibrosis. 
